Goto, Rei

写真a

Affiliation

Graduate School of Business Administration ( Hiyoshi )

Position

Professor
Scopus Paper Info  
Paper Count: 113 Citation Count: 1299 h-index: 22

Click to view the Scopus page. The data was downloaded from Scopus API in October 25, 2026, via http://api.elsevier.com and http://www.scopus.com .

Page Top ▲

Other Affiliation 【 Display / hide 】

  • Graduate School of Health Management

Page Top ▲

Career 【 Display / hide 】

  • 1998.05
    -
    2000.03

    Kobe City General Hospital, Resident in Medicine

  • 2005.04
    -
    2007.03

    Konan University, Faculty of Economics, Lecturer

  • 2007.04
    -
    2012.03

    Konan University, Faculty of Economics, Associate Professor

  • 2012.04
    -
    2016.03

    Kyoto University, The Hakubi Institute of Advanced Research, Associate Professor

Page Top ▲

Academic Background 【 Display / hide 】

  • 1992.04
    -
    1998.03

    Kyoto University, School of Medicine

    University, Graduated, Other

  • 2000.04
    -
    2005.03

    Kyoto University, Graduate School of Economics

    Graduate School, Completed, Doctoral course

Page Top ▲

Academic Degrees 【 Display / hide 】

  • 学士（医学）, Kyoto University, Coursework, 1998.03

  • 博士（経済学）, Kyoto University, Coursework, 2006.05

Page Top ▲

Licenses and Qualifications 【 Display / hide 】

  • Physician, 1998.04

Page Top ▲
 

Research Areas 【 Display / hide 】

  • Humanities & Social Sciences / Economic policy

  • Humanities & Social Sciences / Public economics and labor economics

  • Life Science / Medical management and medical sociology

Page Top ▲

Research Keywords 【 Display / hide 】

  • health technology assessment

  • health policy

  • health economics

  • behavioral economics

Page Top ▲
 

Books 【 Display / hide 】

  • Health Economics

    後藤励, 井深陽子, 有斐閣, 2020.03

  • 医療レジリエンス　－医学アカデミアの社会的責任－

    FUKUHARA Shunichi,GOTO Rei,NAKAYAMA Takeo,KAWAKAMI Koji,FUKUMA Shingo, 医学書院, 2015

  • 日本のお医者さん研究

    MORI Takeshi,GOTO Rei, 東洋経済新報社, 2012

  • 医療経済学講義

    GOTO Rei, 東京大学出版会, 2011

    Scope: 第１０章　生活習慣と行動変容

  • 健康行動経済学

    YODA Takanori,GOTO Rei,NISHIMURA Shuzo, 日本評論社, 2009

display all >>

Page Top ▲

Papers 【 Display / hide 】

  • Cost-Effectiveness Analysis of Fecal Immunochemical Test-based Versus Total Colonoscopy-Based Colorectal Cancer Screening in Japan: A Microsimulation Study

    Mori T., Shimohata N., Goto R.

    Value in Health Regional Issues 59 2027.05

    ISSN  22121099

    　View Summary

    Objectives Colorectal cancer is a major public health concern with a high mortality rate. Fecal immunochemical tests (FIT) and total colonoscopy (TCS) are recommended screening methods; however, their cost-effectiveness varies by country. This study addressed the lack of comprehensive cost-effectiveness analyses comparing TCS with the current FIT-based screening in Japan. Methods We developed a microsimulation-based decision analytic model to compare FIT-based screening (current practice) with TCS-based screening (alternative) in a hypothetical cohort of 10 000 Japanese adults over a 60-year period. The analysis was conducted from the healthcare payer perspective, with both costs and health outcomes discounted annually by 2%. We adhered to the 2022 Consolidated Health Economic Evaluation Reporting Standards reporting guidelines and incorporated Japan-specific data on costs, participation rates, and disease progression. Results In the base-case analysis, FIT-based screening was more cost-effective than TCS-based screening. TCS-based screening also yielded fewer quality-adjusted life-years, making it the less favorable approach. Sensitivity analyses showed that FIT remained the dominant screening across most parameter variations. Conclusions In Japan, the current FIT-based colorectal cancer screening is more cost-effective than TCS-based screening. Efforts should focus on improving FIT program participation to achieve greater public health benefits, rather than transitioning to a costlier and less effective alternative.

  • Organization-level factors associated with the adoption of care robots in long-term care providers: insights from a 3-year pooled cross-sectional study in Japan

    Tosaka Y., Funada S., Goto R.

    BMC Health Services Research 26 ( 1 )  2026.12

    　View Summary

    Background: Care robots are expected to be useful in long-term care (LTC) settings to resolve several challenges associated with aging populations. However, their use is still limited and little is known about the factors associated with their adoption. This study aimed to identify the factors associated with the adoption of care robots, using a quantitative analysis of a large sample at the organizational level in Japan. Methods: We analyzed residential service providers using 3 years of pooled cross-sectional data from the Fact-Finding Survey on Long-term Care Work in Japan. In this survey, care robots were categorized as robots for “Transfer support,” “Mobility assistance,” “Toiletry support,” “Monitoring and Communication,” “Bathing support,” and “Support for LTC workers.” We defined “adoption of care robots” as LTC providers having adopted at least one of the care robots. To identify the characteristics of LTC providers associated with the adoption of care robots, we conducted a multivariable logistic regression comparing providers with and without care robots. Results: Of the 4,688 LTC providers, 1,250 (26.7%) adopted care robots. The characteristics of LTC providers that were found to be associated with the adoption of care robots were: information and communication technology (ICT) equipment adoption (adjusted odds ratio [aOR] 3.115, 95% confidence interval [CI] 2.453, 3.956), younger average age of care workers (aOR 0.958, 95% CI 0.945, 0.971), large number of employees (aOR 1.008, 95% CI 1.006, 1.010) and appointment of employment management supervisor (aOR 1.611, 95% CI 1.400, 1.853). The primary results were consistent across robot categories. Conclusions: Our findings suggest that care robot adoption is highly compatible with ICT equipment adoption, particularly among younger workers, and among large-scale providers and those with a high awareness of improving employment management indicated by the appointment of an employment management supervisor. To promote adoption, we suggest staff technology-literacy training (especially for senior employees), targeted financial incentives for small providers, and management-led integration of robots within employment-management improvements. This study identified the factors associated with the adoption of care robots at the organizational level and is expected to contribute to realizing the implementation of care robots.

  • Financial burden of menstrual and menopausal symptoms: productivity loss from absenteeism and presenteeism among working-age women

    Kasahara S., Goto R., Suzuki S., Sakamoto H., Okamoto S.

    Reproductive Health 23 ( 1 )  2026.12

    　View Summary

    Background: Women’s participation in the workforce not only promotes equal opportunity but also contributes to strengthening the social and economic development by addressing declining labour force participation rates linked to population ageing. Women have unique sexual and reproductive health needs, which can hinder their workplace participation and advancement. Therefore, understanding those needs is vital to make a work environment gender-responsive and equitable to ensure that all women can fully engage in social and economic activities. This study aims to provide evidence on the financial burden of productivity loss related to menstruation and menopause. Methods: To assess the financial impact of productivity loss due to menstruation- and menopause-related symptoms, we conducted an internet-based, cross-sectional survey in Japan in September 2022. The survey included 10,000 individuals with 4,950 women aged 25–59, of which we analysed 3,046 responses from those in paid work and with necessary information. Using the validated work productivity and activity impairment questionnaire, we assessed the financial burden of productivity loss, focusing on absenteeism and presenteeism, and estimated the national-level cost among working women aged 25 to 59. Results: Results show that approximately 7.0-8.8% of working women experienced absenteeism or reduced working hours because of the symptoms. Specifically, menstruation- and menopause-related absenteeism accounted for 2–3 days off and a reduction of 2–5 working hours in the preceding three months. Additionally, 79.7% of women reported that menstrual or menopausal symptoms impacted their work productivity. Our estimate suggests that the annual financial burden of productivity loss arising from the symptoms at the national level is approximately JPY 2,296.30 billion (USD 14.65 billion), comprising JPY 323.95 billion (USD 2.07 billion) from absenteeism and JPY 1,972.35 billion (USD 12.59 billion) from presenteeism. Discussion: This study highlights the potential of addressing menstruation- and menopause-related symptoms among working-age women in generating positive economic impacts. These findings underscore the need for workplaces to implement gender-responsive strategies that meet the sexual and reproductive health needs of women in order to ensure gender equality and women’s empowerment at workplace.

  • National cost of intensive care in Japan from 2018 to 2022

    Ohbe H., Kudo D., Kushimoto S., Iwasaki Y., Shiga T., Goto R., Nishiyama K., Seo R., Iwagami M., Abe T., Kimura Y., Matsui H., Fushimi K., Yasunaga H.

    Journal of Intensive Care 14 ( 1 )  2026.12

    　View Summary

    Background: Intensive care is a cornerstone of modern health systems, yet it remains among the most resource-intensive and costly forms of care. While intensive care unit (ICU) costs represent a substantial portion of health care expenditures in many high-income countries, national-level data on ICU costs in Japan have been lacking. We aimed to estimate national ICU costs in Japan using administrative and hospital-level data, employing internationally comparable methods. Methods: We conducted a nationwide retrospective cohort study using the Diagnosis Procedure Combination Study Group database and the Hospital Bed Function Report during fiscal years 2018–2022. ICU costs were estimated using a bottom-up costing approach aligned with the method used in major international studies, and focused on certified adult and pediatric ICUs. Macroeconomic impact, temporal trends, and regional variation were assessed. We also analyzed the cost of intermediate care units (IMCU) and IMCU–ICU ratio. Results: A total of 1,453,929 ICU patients were identified in the DPC Study Group database from 2018 to 2022, which covers 68.2% of all ICU beds in Japan. The mean ICU cost per patient-day was ¥197,277 (approximately $1,793 USD), and the estimated national ICU cost over the 2018–2022 period was ¥1,785 billion (mean ¥357 billion per year). This represented 0.065% of nominal gross domestic product (GDP), 0.56% of total health expenditures, 1.42% of hospital expenditures, and 2.17% of inpatient expenditures. The macroeconomic impact of ICU care was stable from 2018 to 2022. The proportion of ICU costs relative to nominal GDP, total health expenditures, and hospital expenditures in Japan was substantially lower than in the United States, Canada, and Australia. Regional variation was pronounced, with up to a 7.5-fold difference across prefectures. The estimated national IMCU cost over the 2018–2022 period was ¥2,838 billion (mean ¥568 billion per year), approximately 1.5 times greater than ICU cost (IMCU–ICU ratio is approximately 1.59). Conclusions: This study provides the first comprehensive national estimates of ICU costs in Japan using internationally aligned methods. These findings indicate lower ICU spending in Japan than in other high-income countries.

  • 特集 持続可能な医療制度に向けて--医療経済・政策学によるアプローチ 医療技術評価と医療経済評価

    後藤 励

    医学のあゆみ (医歯薬出版)  298 ( 6 ) 481 - 485 2026.08

    ISSN  00392359

display all >>

Page Top ▲

Papers, etc., Registered in KOARA 【 Display / hide 】

Page Top ▲

Reviews, Commentaries, etc. 【 Display / hide 】

  • Publisher Correction: The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025) (Hypertension Research, (2026), 49, 1, (9-235), 10.1038/s41440-025-02462-y)

    Ohya Y., Arakawa K., Arata N., Arima S., Arima H., Asayama K., Dohi Y., Fukami A., Furuhashi M., Goto K., Goto R., Hatta T., Hirawa N., Hirooka Y., Hisamatsu T., Hoshide S., Ikezumi Y., Inoue S., Ishida M., Ishimitsu T., Iwashima Y., Kabayama M., Kabutoya T., Kai H., Kaneko H., Kanno Y., Katsuya T., Kikuchi T., Koga M., Kudo M., Kuwabara M., Matsumura K., Metoki H., Mito A., Miura S.I., Miura K., Miyashita K., Mogi M., Kawakami-Mori F., Morimoto S., Mukai M., Mukoyama M., Munakata M., Nakagawa N., Ohkubo T., Okura T., Rakugi H., Shibata S., Shinohara K., Takami T., Takase H., Takemi Y., Tanaka A., Tomiyama H., Toyoda K., Tsuchihashi T., Ueda S., Yamamoto E., Yamamoto K., Sakima A.

    Hypertension Research 49 ( 4 )  2026.04

    ISSN  09169636

    　View Summary

    Correction to: Hypertension Research https://doi.org/10.1038/s41440-025-02462-y, published online 01 January 2026 In the original version of this article, the author list was incorrectly located in the article body. The original article has been corrected.

  • Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis

    Noda K., Lim Y., Goto R., Sengoku S., Kodama K.

    Drug Discovery Today (Drug Discovery Today)  29 ( 3 )  2024.03

    ISSN  13596446

    　View Summary

    Dementia management has evolved with drugs such as lecanemab, shifting management from palliative care to early diagnosis and intervention. However, the administration of these drugs presents challenges owing to the invasiveness, high cost and limited availability of amyloid-PET and cerebrospinal fluid tests for guiding drug administration. Our manuscript explores the potential of less invasive blood biomarkers as a diagnostic method, with a cost-effectiveness analysis and a comparison with traditional tests. Our findings suggest that blood biomarkers are a cost-effective alternative, but with lower accuracy, indicating the need for multiple specific biomarkers for precision. This underscores the importance of future research on new blood biomarkers and their clinical efficacy.

  • Re: Letter to the Editor of Public Health in response to ‘Effect of influenza vaccine subsidies for older adults on vaccination coverage and mortality before and during the COVID-19 pandemic: An ecological study in Japan’

    Ando T., Ibuka Y., Goto R., Haruta J., Le D.D., Fujishima S.

    Public Health (Public Health)  227   e3 - e4 2024.02

    ISSN  00333506

  • Health-related quality of life assessment in children for economic evaluation

    HONDA Kimiko, SHIROIWA Takeru, GOTO Rei, FUKUDA Takashi

    Journal of the National Institute of Public Health (National Institute of Public Health)  71 ( 3 ) 264 - 275 2022.08

    ISSN  1347-6459

    　View Summary

    <p>The use of quality-adjusted life year (QALY) as a measure of benefit is recommended in economic evaluation, which aims to provide evidence for the appropriate allocation of health care resources. This allows for an easier comparison of interventions' effects in different fields. A QALY value is calculated by weighting the life years (LYs) by the quality of life (QOL) score, which is determined by preference-based measure (PBM) and converted from 0 to 1. The QOL score should be obtained through domestic surveys because it reflects the value in the country's general population. In Japan, the data of the QOL scores for adults have been accumulated in recent years. However, few studies for children have been conducted due to various issues in evaluating pediatric health-related QOL (HRQOL). The PBM process for obtaining the QOL score can be divided into “measurement” and “valuation” of the health state to be evaluated. This process is implemented at once in direct methods, whereas it is carried out separately in indirect methods. Direct methods include the rating scale, the time trade-off, and the standard gamble, but children's feasibility, reliability, and validity must be thoroughly investigated. In indirect methods, which is currently the mainstream in general, multi-attribute utility instruments (MAUIs) are used, consisting of a questionnaire to measure the health state and a value set to value the measured health state. However, most MAUIs are designed for adult use and are not suitable for pediatric use because the questions are inappropriate, and the value set is intended to value adult health. In recent years, some MAUIs for pediatric use have been developed. Nevertheless, due to translations and the value set, these are not available in all countries. Additionally, there are no existing MAUIs available for children aged 3 years. Furthermore, issues concerning “measurement,” such as which domains should be assessed and how, and by whom, and issues concerning “valuation,” such as whose preferences should be reflected in developing the value set, and which perspectives should be used, remain. There have been no MAUIs for pediatric use in Japan, but the Japanese version of the EuroQol 5-dimension Youth version (EQ-5D-Y) and its value set have recently been published. It is necessary to fully understand the challenges and limitations in measuring and interpreting the QOL score in children.</p>

  • 【すぐそこまで来た,医師の働き方改革-課題と実現可能性】医師の働き方改革とお金の問題

    後藤 励

    病院 ((株)医学書院)  81 ( 2 ) 127 - 129 2022.02

    ISSN  0385-2377

display all >>

Page Top ▲

Research Projects of Competitive Funds, etc. 【 Display / hide 】

  • Platform development of claim data analysis for economic analysis of health policy

    2015.04
    -
    2018.03

    MEXT,JSPS, Grant-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Principal investigator

Page Top ▲
 

Courses Taught 【 Display / hide 】

  • PRINCIPLES OF HEALTH MANAGEMENT

    2026

  • HEALTH BEHAVIOR SCIENCE

    2026

  • JOINT SEMINAR ON HEALTH MANAGEMENT

    2026

  • HEALTHECONOMICS

    2026

  • ADVANCED STUDIES IN HEALTH MANAGEMENT 2

    2026

display all >>

Page Top ▲